Childhood psoriasis: A review of literature
Keywords:
Psoriasis, childhood, systemic therapy, topical therapyAbstract
Psoriasis is a chronic inflammatory, immune-mediated disease in which one-third of patients suffer under the age of 18 years. In early age, the diagnosis may be difficult because of the atypical lesions. Plaque type of psoriasis is the commonest form of childhood psoriasis. Phototherapy as well as systemic therapy used in childhood psoriasis has limited use because of the long-term side effects of the drugs like teratogenicity, low tolerance, and other liver, renal and hematological derangements. In this review, the update on clinical aspects of childhood psoriasis, its onset, precipitating factors, demographics, pathogenesis and therapeutic options are discussed.ÂReferences
Kurd SK, Gelfand JM. The prevalence of previously diagnosed and undiagnosed psoriasis in US adults: results from NHANES 2003-2004. J Am Acad Dermatol 2009; 60: 218-24.
Silverberg NB. Pediatric psoriasis: an update. Ther Clin Risk Manag 2009; 5: 849-56.
Lehman JS, Rahil AK. Congenital psoriasis: Case report and literature review. Pediatr Dermatol 2008; 25: 332-38.
Marcoux D, Prost Y. Pediatric psoriasis revisited. J Cutan Med Surg 2002; 6 (Suppl l): 22-8.
Burden AD. Management of psoriasis in childhood. Clin Exp Dermatol 1999; 24: 341-5.
Morris A, Rogers M, Fischer G, Williams K. Childhood psoriasis: a clinical review of 1262 cases. Pediatr Dermatol 2001; 18: 188-98.
Kumar B, Jain R, Sandhu K et al. Epidemiology of childhood psoriasis: a study of 419 patients from northern India. Int J Dermatol 2004; 43: 654-8.
Fan X, Xiao FL, Yanq S et al. Childhood psoriasis: a study of 277 patients from China. J Eur Acad Dermatol Venereol 2007; 21: 762-5.
Tollefson MG, Crowson CS, McEvoy MT, Kremers HM. Incidence of psoriasis in children: A population based study. J Am Acad Dermatol 2010; 62: 979-87.
de Jager ME, de Jong EM, Meeuwis KA et al. No evidence found that childhood onset of psoriasis influences disease severity, future body mass index of type of treatments used. J Eur Acad Dermatol Venereol 2010; 24: 1333-9.
Seyhan M, Coskun BK, Saglam H et al. Psoriasis in childhood and adolescence: Evaluation of demographic and clinical features. Pediatr Int 2006; 48: 525-30.
Piskitt EM, Cole TJ. Do fat babies stay fat? Br Med J 1977; 1: 7-9.
Herron MD, Hinkley M, Hoffman MS et al. Impact of obesity and smoking on psoriasis presentation and management. Arch Dermatol 2005; 141: 1527-34.
Boccardi D, Menni S, Vecchia CL et al. Overweight and childhood psoriasis. Br J Dermatol 2009; 161: 484-6.
Naldi I, Parrazini F, Peli I et al. Dietary factors and the risk of psoriasis. Results of an Italian case-control study. Br J Dermatol 1996; 134: 101-6.
Cassandra M, Conte E, Cortez B. Childhood pustular psoriasis elicited by the streptococcal antigen: a case report and review of the literature. Pediatr Dermatol 2003; 20: 506-10.
Kopp T, Karlhofer F, Szepfalusi Z et al. Successful use of acitretin in conjunction with narrowband ultraviolet B phototherapy in a child with severe pustular psoriasis, von Zumbusch type. Br J Dermatol 2004; 151: 912-6.
Chao P, Cheng Y, Chung M. Generalized pustular psoriasis in a 6-week-old infant. Pediatr Dermatol 2009; 26: 352-4.
Lehners-Weber C, de la Brassinne M, Dezfoulian B et al. Congenital psoriasis following the lines of Blaschko. Pediatr Dermatol 1996; 13: 219-21.
Al-Fouzan SA, Hassab-El-Nabi HMM, Nanda A. Congenital linear psoriasis: a case report. Pediatr Dermatol 1990; 7: 303-6.
Lerner MR, Lerner AB. Congenital psoriasis: report of three cases. Arch Dermatol 1972; 105: 598-601.
Henriksen L, Zachariae H. Pustular psoriasis and arthritis in congenital psoriasiform erythroderma. Dermatologica 1972; 144: 12-8.
Chang SE, Choi JH, Koh JK. Congenital erythrodermic psoriasis. Br J Dermatol 1999; 140: 538-68.
Li Y, Begovich AB, Unraveling the genetics of complex diseases; susceptibility genes for rheumatoid arthritis and psoriasis. Semin Immunol 2009; 21: 318-27.
Perez-Lorenzo R, Zambrano-Zaragoza JF, Saul A et al. Autoantibodies to autologous skin in guttate and plaque forms of psoriasis and cross-reaction of skin antigens with streptococcal antigens. Int J Dermatol 1998; 37: 524-31.
Balci DD, Duran N, Ozer B, Gunesacar R et al. High prevalence of Staphylococcus aureus cultivation and superantigen production in patients with psoriasis. Eur J Dermatol 2009; 19:238-42.
Simeone P, Teson M, Latini A et al. Human papillomavirus type 5 in primary keratinocytes from psoriatic skin. Exp Dermatol 2005; 14: 824-9.
Prinz JC. Which T cells cause psoriasis? Clin Exp Dermatol 1999; 24: 291-5.
Austin LM, Ozawa M, Kikuchi T et al. The majority of epidermal T cells in psoriasis vulgaris lesions can produce type I cytokines, interferon-γ, interleukin-2 and tumor necrosis factor-α, defining TCI (cytotoxic T lymphocyte) and THI effector populations: a type I differentiation bias is also measured in circulating blood T cells in psoriatic patients. J Invest Dermatol 1999; 113: 757-9.
Lowes MA, Kikuchi T, Fuentes-Duculan J et al. Psoriasis vulgaris lesions contain discrete populations of Th1 and Th17 T cells. J Invest Dermatol 2008; 128: 1207-11.
Leigh IM, Navsaria H, Purkis PE et al. Keratins (K16 and K17) as markers of keratinocyte hyperproliferation in psoriasis in vivo and vitro. Br J Dermatol 1995; 133: 501-11.
Huffmeier U, Lascorz J, Becker T et al. Characterization of psoriasis susceptibility locus 6 (PSORS6) in patients with early onset psoriasis and evidence for interaction with PSORI. J Med Genet 2009; 46: 736-44.
Burden AD. Management of psoriasis in childhood. Clin Exp Dermatol 1999; 24: 341-5.
Beattie PE, Lewis-Jones MS. A comparative study of impairment of quality of life in children with skin disease and children with other chronic childhood diseases. Br J Dermatol 2006; 155: 145-51.
Kimball AB, Gold MH, Zib B, Davis MW. Clobetasol propionate emulsion formulation foam phase III clinical study group. Clobetasol propionate emulsion formulation foam 0.05%: review of phase IIopen-label and phase III randomized controlled trials in steroid-responsive dermatoses in adults and adolescents. J Am Acad Dermatol 2008; 59: 448-54.
Kiken DA, Silverberg NB. Atopic dermatitis in children, part 2: treatment options. Cutis 2006; 78: 401-6.
Farber EM, Nall L. Childhood psoriasis. Cutis 1999; 64: 309-314.
Oranje AP, Marcoux D, Svensson A et al. Topical calcipotriol in childhood psoriasis. J Am Acad Dermatol 1997; 36: 203-8.
Jain VK, Aggarwal K, Jain K et al. Narrow-band UV-B phototherapy in childhood psoriasis. Int J Dermatol 2007; 46; 320-2.
Ersoy-Evans S, Altaykan A, Sahin S, Kolemen F. Phototherapy in childhood. Clinical and laboratory investigations. Pediatr Dermatol 2008; 25: 599-605.
Al-Fouzan AS, Nanda A. UVB phototherapy in childhood psoriasis. Pediatr Dermatol 1995; 12: 66.
Jury CS, McHenry P, Burden AD et al. Narrow-band ultraviolet B (UVB) phototherapy in children. Clin Exp Dermatol 2006; 31: 196-9.
Tay YK, Morelli JG, Weston WL. Experience with UVB phototherapy in children. Pediatr Dermatol 1996; 13: 406-9.
Cassandra M, Conte E, Cortez B. Childhood pustular psoriasis elicited by the streptococcal antigen: a case report and the review of the literature. Pediatr Dermatol 2003; 20: 506-10.
Wilson JK, Al-Suwaidan SN, Krowchuk D et al. Treatment of psoriasis in children: is there a role of antibiotic therapy and tonsillectomy? Pediatr Dermatol 2003; 20: 11-5.
Dogan B, Karabudak O, Harmanyeri Y. Antistreptococcal treatment of guttate psoriasis: a controlled study. Int J Dermatol 2008; 47: 950-2.
Juanqin G, Zhiqiang C, Zijia H. Evaluation of the effectiveness of childhood generalized pustular psoriasis treatment in 30 cases. Pediatr Dermatol 1998; 15: 144-6.
Patrizi A, Costa AM, Fiorillo L, Neri I. Perianal streptococcal dermatitis associated with guttate psoriasis and/or balanoposthitis: a study of five cases. Pediatr Dermatol 1994; 11: 168-71.
Pacifico L. Acute guttate psoriasis after streptococcal scarlet fever. Pediatr Dermatol 1993; 10: 388-9.
Cordoro KM. Systemic and light therapies for the management of childhood psoriasis: part II. Skin Ther Lett 2008; 13: 1-3.
Kilic SS, Hacimustafaoglu M, Celebi S et al. Low dose cyclosporin A treatment in generalized pustular psoriasis. Pediatr Dermatol 2001; 18: 246-8.
Alli N, Gungor E, Karakayali G et al. The use of cyclosporine in a child with generalized pustular psoriasis. Br J Dermatol 1998; 139: 754-5.
Mahe E, Bodemer C, Pruszkowski A et al. Cyclosporin in childhood psoriasis. Arch Dermatol 2001; 137: 1532-3.
Davis A, Krafchik BR. New drugs in pediatric dermatology. Curr Opin Pediatr 1993; 5: 212-5.
Rosinska D, Wolska H, Jablonska S, Koncha I. Etretinate in severe psoriasis of children. Pediatr Dermatol 1988; 5:266-72.
Al-Shobaili H, Al-Khenaizan S. Childhood generalized pustular psoriasis: successful treatment with isotretinoin. Pediatr Dermatol 2007; 24: 563-4.
Collin B, Ogboli M, Moss C. Methotrexate therapy in 10 children with severe plaque psoriasis: P-29. Br J Dermatol 2006; 155 (Suppl): 33.
Kumar B, Dhar S, Handa S, Kaur I. Methotrexate in childhood psoriasis. Pediatr Dermatol 1994; 11: 271-3.
Dogra S, Kumaran MS, Handa S, Kanwar AJ. Methotrexate for generalized pustular psoriasis in a 2-year-old child. Pediatr Dermatol 2005; 22: 85-6.
Kalla G, Goyal AM. Juvenile generalized pustular psoriasis. Pediatr Dermatol 1996; 13:45-6.
Lovell DJ, Reiff A, Ilowite NT et al. Pediatric Rheumatology Collaborative study group. Safety and efficacy of up to eight years of continuous etanercept therapy in patients with juvenile rheumatoid arthritis. Arthritis Rheum 2008; 58: 1496-1504.
Paller AS, Siegfried EC, Langley RG et al. Etanercept treatment of children and adolescents with plaque psoriasis. N Engl J Med 2008; 358: 241-51.
Farnsworth NN, George SJ, Hsu S. Successful use of infliximab following a failed course of etanercept in a pediatric patient. Dermatol Online J 2005; 11: 11.
Safa G, Loppin M, Bousser AM, Barbarot S. Etanercept in a 7-year-old boy with severe and recalcitrant psoriasis. J Am Acad Dermatol 2007; 56 (Suppl): S19-20.
Papoutsaki M, Costanzo A, Massotta A et al. Etanercept for the treatment of severe childhood psoriasis. Br J Dermatol 2006; 154: 181-3.
